Output details
1 - Clinical Medicine
Institute of Cancer Research
Article title
Treatment with trastuzumab for 1 year after adjuvant chemotherapy in patients with HER2-positive early breast cancer: a 4-year follow-up of a randomised controlled trial
Type
D - Journal article
Title of journal
LANCET ONCOLOGY
Article number
-
Volume number
12
Issue number
3
First page of article
236
ISSN of journal
1470-2045
Year of publication
2011
URL
-
Number of additional authors
25
Additional information
a. The author made a substantial contribution to the conception and design of the study. The author made a substantial contribution to the organisation of the conduct of the study. The author made a substantial contribution to carrying out the study (including acquisition of study data). The author made a substantial contribution to analysis and interpretation of study data. b. The author helped draft the output.
Interdisciplinary
-
Cross-referral requested
-
Research group
None
Citation count
115
Proposed double-weighted
No
Double-weighted statement
-
Reserve for a double-weighted output
No
Non-English
No
English abstract
-